These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16479248)

  • 21. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
    Djokić DDj; Janković DLj; Stamenković LLj; Pirmettis I
    Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99mTc carbonyl t-butyl isonitrile: a potential new agent for myocardial perfusion imaging.
    Kothari KK; Satpati D; Joshi S; Venkatesh M; Ramamoorthy N; Pillai MR
    Nucl Med Commun; 2005 Feb; 26(2):155-61. PubMed ID: 15657510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT).
    Francis RJ; Mather SJ; Chester K; Sharma SK; Bhatia J; Pedley RB; Waibel R; Green AJ; Begent RH
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1090-6. PubMed ID: 15029458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial uptake and biodistribution of newly designed technetium-labelled fatty acid analogues.
    Heintz AC; Jung CM; Stehr SN; Mirtschink P; Walther M; Pietzsch J; Bergmann R; Pietzsch HJ; Spies H; Wunderlich G; Kropp J; Deussen A
    Nucl Med Commun; 2007 Aug; 28(8):637-45. PubMed ID: 17625386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression.
    Femia FJ; Maresca KP; Hillier SM; Zimmerman CN; Joyal JL; Barrett JA; Aras O; Dilsizian V; Eckelman WC; Babich JW
    J Nucl Med; 2008 Jun; 49(6):970-7. PubMed ID: 18483087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (99m)Tc-prulifloxacin in artificially infected animals. Radiosynthesis and biological evaluation.
    Shah SQ; Khan AU; Khan MR
    Nuklearmedizin; 2011; 50(3):134-40. PubMed ID: 21340097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality control validation for exogenous natural surfactant labeled with 99mTc.
    Calmanovici GP; Salgueiro MJ; Leonardi NM; Goldman CG; Nicolini JO; Boccio JR; Caro RA; Zubata PD; Zubillaga MB
    J Nucl Med Technol; 2005 Dec; 33(4):234-7. PubMed ID: 16322125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
    Zhuang ZP; Kung MP; Mu M; Hou C; Kung HF
    Bioconjug Chem; 1999; 10(2):159-68. PubMed ID: 10077463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative biological evaluation of two [99mTc(CO)3]-dextran pyrazolyl mannose conjugates developed for use in sentinel lymph node detection.
    Subramanian S; Pandey U; Morais M; Correia JD; Santos I; Samuel G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):216-23. PubMed ID: 24172653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
    Zhuang ZP; Kung MP; Hou C; Ploessl K; Kung HF
    Nucl Med Biol; 2005 Feb; 32(2):171-84. PubMed ID: 15721763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
    Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.
    Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M
    Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
    Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK
    Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of one novel technetium-99m-labeled nitroquipazine derivative as an imaging agent for serotonin transporter.
    Guo Y; Chen X; Jia H; Ji X; Liu B
    Appl Radiat Isot; 2008 Dec; 66(12):1804-9. PubMed ID: 18684634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and in-vivo evaluation of 99mTc-IOTIDA for cholescintigraphy.
    Hong YD; Jang BS; Choi SM; Park WW; Park KB; Choi SJ
    Appl Radiat Isot; 2004 Dec; 61(6):1273-8. PubMed ID: 15388121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.
    King R; Surfraz MB; Finucane C; Biagini SC; Blower PJ; Mather SJ
    J Nucl Med; 2009 Apr; 50(4):591-8. PubMed ID: 19289435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of an estradiol glucuronide derivative and investigation of its radiopharmaceutical potential.
    Biber FZ; Unak P; Ertay T; Medine EI; Zihnioglu F; Tasci C; Durak H
    Appl Radiat Isot; 2006 Jul; 64(7):778-88. PubMed ID: 16531048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, characterization and biological evaluation of novel neutral fac-M(CO)3(SNO) complexes (M=Re, 99mTc) bearing the o-methoxyphenylpiperazine moiety.
    Chiotellis A; Tsoukalas C; Pelecanou M; Pirmettis I; Papadopoulos M
    Appl Radiat Isot; 2012 Jun; 70(6):957-64. PubMed ID: 22464790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.
    Engfeldt T; Tran T; Orlova A; Widström C; Feldwisch J; Abrahmsen L; Wennborg A; Karlström AE; Tolmachev V
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1843-53. PubMed ID: 17565496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
    Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.